RecruitingNCT05848310
Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
Sponsor
Children's Hospital of Fudan University
Enrollment
200 participants
Start Date
Oct 15, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
To investigate the role of preoperative serum FGF19 level in the prognosis of biliary atresia.
Eligibility
Inclusion Criteria4
- Samples diagnosed as biliary atresia in Children's Hospital of Fudan University
- Samples with one-year follow-up records after surgery
- Samples with a record of serum total bilirubin levels three months after surgery
- Samples with preoperative serum left（volume \> 500ul)
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05848310
Related Trials
High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
NCT050726261 location
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
NCT072508541 location
Personalized First-line Chemotherapy Choice in Advanced Pancreatic Adenocarcinoma Using Transcriptomic Signatures
NCT054753667 locations
Thrombus Composition in Ischemic Stroke: Analysis of the Correlation With Plasma Biomarkers, Efficacy of Treatment, Etiology and Prognosis
NCT0326866812 locations
Nutritional Intervention for Biliary Atresia
NCT067640821 location